The more fundamental question is not when will Leo secure a deal. It’s if Leo will secure any deal at all. Consider that he has failed to secure a deal for Kevetrin, which went from life support to the morgue. He failed to secure a deal for absssi, which seemingly has very good results and a real sample size. So the question is if not when. I had always figured Leo could ink some deal, even if it was only for 5-10mm upfront. But now I’m not even confident in that. Of course, Leo could prove me absolutely wrong.
News 
Market Data 
Discover 
